Clinical Trial Update: The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C) [NA]

View source ↗

Summary

The Canadian STICH3C trial evaluating CABG or PCI in patients with ischemic cardiomyopathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Failure with Reduced Ejection Fraction
• Ischemic Cardiomyopathy

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Coronary Artery Disease, Heart Failure Systolic | NA | Status: RECRUITING